Functional Evaluation of Two Types of Totally Implanted Venous Ports
Primary Purpose
Hematologic Disease
Status
Completed
Phase
Not Applicable
Locations
Belgium
Study Type
Interventional
Intervention
Vortex port and Celsite port
Sponsored by
About this trial
This is an interventional supportive care trial for Hematologic Disease focused on measuring oncology, medical, implantable catheter, vascular access ports, persistent withdrawal occlusion, Vortex®, Celsite®, Vacutainer®, venous cut-down
Eligibility Criteria
Inclusion Criteria:
- request of a standard size totally implanted venous port
- patent superior vena cava
- normal clotting tests (PT>40% and platelet count >40000/mm3)
Exclusion Criteria:
- unable to provide written informed consent
Sites / Locations
- University Hospitals Leuven
Outcomes
Primary Outcome Measures
Evaluation of the difference in difficulty in blood drawing between the 2 types of ports when accessing the port under identical maintenance procedure according to the guidelines in the University Hospitals Leuven.
Evaluation of the difference in one-way or bidirectional occlusion incidence between these 2 types of ports, when accessing the port under identical maintenance procedure according to the guidelines in the University Hospitals Leuven.
Evaluation of the difference in filling time for blood sampling between these 2 types of ports when using a standard 10 ml vacuum blood tube and a 19 G Gripper® needle.
Secondary Outcome Measures
Evaluation of the ease of use (ease of access) between these 2 types of ports when accessing the port.
Full Information
NCT ID
NCT00484848
First Posted
June 7, 2007
Last Updated
January 23, 2009
Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
RITA Medical Systems, B. Braun Medical SA
1. Study Identification
Unique Protocol Identification Number
NCT00484848
Brief Title
Functional Evaluation of Two Types of Totally Implanted Venous Ports
Official Title
Functional Evaluation of Conventional Venous Access Port (Celsite®) Versus Venous Access Port With Tangential Outlet (Vortex®) : a Prospective Randomized Pilot Study
Study Type
Interventional
2. Study Status
Record Verification Date
January 2009
Overall Recruitment Status
Completed
Study Start Date
September 2004 (undefined)
Primary Completion Date
December 2004 (Actual)
Study Completion Date
March 2005 (Actual)
3. Sponsor/Collaborators
Name of the Sponsor
Universitaire Ziekenhuizen KU Leuven
Collaborators
RITA Medical Systems, B. Braun Medical SA
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Totally implanted venous access ports allow a safe delivery of medication, mainly chemotherapy, but are also used for blood sampling. This last procedure is not always successful, as it appeared from a nurse's survey in different hospitals in Flanders, including the University Hospitals in Leuven, Belgium. In 3 to 29 percent of the attempts, blood withdrawal is impaired or not possible, as an intermittent or permanent fact. This is in line with international literature data where difficulty in blood draw was noted in 6 to 26% of port accessions. Partial or total occlusion leads to discomfort for the patient, delay in therapy, higher costs and extra nursing time.
A new port system with a tangential outlet (Vortex port) was designed and according to the manufacturer, this shape will allow to cleanse the entire reservoir of the port more efficiently and avoid the formation of precipitates of medication or blood that could lead to an obstruction of the device. These precipitates are also regarded as a potential risk factor for infection.
However, only one previously published small randomised study addressed the value of the Vortex port when compared to conventional access devices: Stevens et al. were able to show a reduction in obstruction incidence from 26% to 7% with the use of the Vortex port. The incidence of blood withdrawal problems in our experience with conventional ports in University hospitals Leuven was 8% thus lower than that reported by Stevens, but this remains the most frequent problem faced by care providers and patients.
With this study, the investigators aim to compare the performance of the tangential outlet ports and that of a "conventional" port in order to assess an eventual functional difference.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hematologic Disease
Keywords
oncology, medical, implantable catheter, vascular access ports, persistent withdrawal occlusion, Vortex®, Celsite®, Vacutainer®, venous cut-down
7. Study Design
Primary Purpose
Supportive Care
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Care Provider
Allocation
Randomized
Enrollment
200 (Actual)
8. Arms, Groups, and Interventions
Intervention Type
Device
Intervention Name(s)
Vortex port and Celsite port
Primary Outcome Measure Information:
Title
Evaluation of the difference in difficulty in blood drawing between the 2 types of ports when accessing the port under identical maintenance procedure according to the guidelines in the University Hospitals Leuven.
Time Frame
up to a maximum of 6 months after insertion
Title
Evaluation of the difference in one-way or bidirectional occlusion incidence between these 2 types of ports, when accessing the port under identical maintenance procedure according to the guidelines in the University Hospitals Leuven.
Time Frame
up to a maximum of 6 months after insertion
Title
Evaluation of the difference in filling time for blood sampling between these 2 types of ports when using a standard 10 ml vacuum blood tube and a 19 G Gripper® needle.
Time Frame
immediately after insertion and up to a maximum of 6 months afterwards
Secondary Outcome Measure Information:
Title
Evaluation of the ease of use (ease of access) between these 2 types of ports when accessing the port.
Time Frame
up to a maximum of 6 months after insertion
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
request of a standard size totally implanted venous port
patent superior vena cava
normal clotting tests (PT>40% and platelet count >40000/mm3)
Exclusion Criteria:
unable to provide written informed consent
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marguerite Stas, MD PhD
Organizational Affiliation
KU Leuven
Official's Role
Principal Investigator
Facility Information:
Facility Name
University Hospitals Leuven
City
Leuven
ZIP/Postal Code
3000
Country
Belgium
12. IPD Sharing Statement
Citations:
Citation
Stevens B, Barton SE, Brechbill M, Moenter S, Piel AL, Shankle D. A Randomized, Prospective Trial of Conventional Vascular Ports Vs.the Vortex
Results Reference
background
PubMed Identifier
16278752
Citation
Lamont JP, McCarty TM, Stephens JS, Smith BA, Carlo J, Livingston S, Kuhn JA. A randomized trial of valved vs nonvalved implantable ports for vascular access. Proc (Bayl Univ Med Cent). 2003 Oct;16(4):384-7. doi: 10.1080/08998280.2003.11927932.
Results Reference
background
PubMed Identifier
18414904
Citation
Goossens GA, Verbeeck G, Moons P, Sermeus W, De Wever I, Stas M. Functional evaluation of conventional 'Celsite' venous ports versus 'Vortex' ports with a tangential outlet: a prospective randomised pilot study. Support Care Cancer. 2008 Dec;16(12):1367-74. doi: 10.1007/s00520-008-0436-y. Epub 2008 Apr 15.
Results Reference
result
Learn more about this trial
Functional Evaluation of Two Types of Totally Implanted Venous Ports
We'll reach out to this number within 24 hrs